Skip to content

Effect of metformin on body composition in elderly patients with type 2 diabetes mellitus

Effect of metformin on body composition in elderly patients with type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042509
Enrollment
Unknown
Registered
2021-01-22
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus, type 2

Interventions

Metformin group:Nil
Non Metformin group:Nil

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Subjects over 60 years old; 2. Subjects who met who diagnostic criteria for diabetes (1999); 3. Volunteers.

Exclusion criteria

Exclusion criteria: 1. Patients with hyperthyroidism, hypothyroidism, depression, malignant tumor, severe heart, liver and kidney insufficiency, systemic infection, etc; 2. Patients with multiple sclerosis, muscular dystrophy, Parkinson's disease and other diseases that affect muscle strength and muscle mass; 3. Patients with acute cardiovascular and cerebrovascular accidents in recent 3 months; 4. Patients with implanted electronic devices (such as pacemaker) or surgical metal materials in vivo; 5. Patients taking hormone, weight loss drugs and muscle enhancing products recently; 6. Patients with poor compliance and mobility can not go to the designated place to cooperate with data collection.

Design outcomes

Secondary

MeasureTime frame
TG;LDL-C;INS;FBS;

Primary

MeasureTime frame
irisin;HbA1c;Body composition;

Countries

China

Contacts

Public ContactTianfeng Wu

Zhejiang Hospital

wwttff2006@126.com+86 13357102785

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026